Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, ...

Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a ...

Novo Nordisk carries a Zacks Rank #5 (Strong Sell), whereas Amgen carries a Zacks Rank #3 (Hold) at present, which makes AMGN ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

The company’s latest preview report projects a guarded rebound for biopharma, as investor confidence returns and M&A activity ...

Biosimilar partnerships and EU approvals surge, enhancing access to innovative treatments in immunology, oncology, and bone health markets.

The FDA approved Scinopharm's glatiramer acetate injection, a generic version of Copaxone, to treat multiple sclerosis.

Samsung Bioepis said Tuesday it has received approval from Japan’s Ministry of Health, Labor and Welfare for SB17, or ustekinumab, a biosimilar to the autoimmune disease treatment Stelara. Stelara, ...

Ustekinumab BS Subcutaneous Injection 45mg Syringes 'NIPRO' has been granted marketing approval in Japan First marketing approval under the partnership with NIPRO CORPORATION, paving the way for ...

'Unanswered Questions' reported that the person called 'injection aunt' may have been a foreign patient recruitment agent rather than a medical professional, raising serious concerns about ...

This is a preview article written based on materials provided by the broadcaster. In "Curious Story Y," it highlights the "injection aunt gate" that started with Park Narae. The episode airing on the ...

Johnson & Johnson’s JNJ stock has been consistently trading above its 50-day and 200-day simple moving averages (SMAs) since the end of June. It achieved the golden cross in mid-July. The 50-day ...